Cure with SR18662 considerably lessens advancement and proliferation of CRC cells. SR18662 demonstrates improved efficacy in minimizing viability of multiple CRC cell lines. Movement cytometry Investigation adhering to SR18662 treatment method demonstrates an increase in cells captured in both S or G2/M phases on the mobile cycle and a major https://nikitag186swa8.yourkwikimage.com/user